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Introduction
During the past decade the number of laboratories
investigating immune senescence has increased dramati-
cally, rapidly advancing our understanding of how the
immune systems of higher organisms change with age.
Historically, aging has been thought of as a state of
immune deficiency. Elderly individuals present with
increased susceptibility to, and severity of, infectious
diseases and decreased vaccine efficacy. More recently,
however, the status of the aged-immune system has been
described as dysregulated [1] or remodeled [2]. Age-
associated changes in both phenotype and function have
been reported for many cell types, including T cells,
B cells, natural killer (NK) cells, and follicular dendritic
cells (FDCs; for review see [3]). The consequences of
these changes are seen in all phases of immunity –
cellular, humoral, and innate.
Not surprisingly, with this wave of new information has
come controversy, as conflicting reports have emerged in
quick succession. Close examination of this literature,
however, reveals that many apparent discrepancies can
be reconciled when trends, rather than specific details, are
analyzed. With this in mind, our review focuses on age-
associated alterations in the B cell compartment in both
mice and humans. Specifically, we believe that on balance
the literature indicates that B lymphopoiesis declines with
age, and that this decline ‘drives’ the selection of antigen-
experienced B cells in the peripheral B cell compartment.
Over time large numbers of antigen-experienced B cells,
including poly/self-reactive subtypes such as marginal
zone (MZ) and CD5+ B1-like cells, accumulate and
eventually dominate the periphery. Finally, we discuss how
this antigen-experienced repertoire is maintained and what
role it may play in the deterioration of humoral immunity
that is evident in many aged individuals.
Age-associated impairment in B lymphopoiesis
Most available evidence indicates that aging is associated
with a decline in B lymphopoiesis. For the purpose of the
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Abstract
Immunosenescence is associated with a decline in both T and B lymphocyte function. Although aged
individuals have normal numbers of B cells in the periphery and are capable of mounting robust humoral
responses, the antibodies produced are generally of lower affinity and are less protective than those
produced by young animals. Here we review multiple studies that address the mechanisms that
contribute to this decline. Taken together, these studies suggest that age-associated loss of the ability
to generate protective humoral immunity results in part from reduced B lymphopoiesis. As the output of
new, naïve B cells declines, homeostatic pressures presumably force the filling of the peripheral B cell
pool by long-lived antigen-experienced cells. Because the antibody repertoire of these cells is restricted
by previous antigenic experience, they make poor quality responses to new immunologic insults.
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present review we consider B lymphopoiesis in terms both
of the complex process of mature B cell development from
committed bone marrow (BM) progenitors, and of the rate
at which new cells are produced and progress from one
developmental stage to another.
In adult mice, development of B cells occurs in the BM in
a series of steps that are definable by changes in cell
surface expression of a variety of molecules (for detailed
reviews, see [4–7]), and is dependent on IL-7 and other
factors made by stromal cells [8]. Current models hold
that the first lineage committed B cell precursors derive
from common lymphoid precursors. Among the earliest
definable B lineage committed cells are pro-B cells. Pro-B
cells express very low levels of cell surface Ig-α and Ig-β,
which transduce signals, supporting immunoglobulin
heavy chain (IgH) gene rearrangement and differentiation
into pre-B cells. In turn, pre-B cells express on their
surfaces low levels of rearranged IgH in association with
Ig-α/β and surrogate light chains λ5 and VpreB. These
cells/clones expand, and then undergo immunoglobulin
light chain (IgL) rearrangement. Expression of rearranged
light chains in association with µ heavy chains and Ig-α/β
marks the transition to the immature B cell stage.
Immature B cells are the earliest cells in the lineage that
express a bona fide antigen specific B cell receptor
(BCR), and therefore they are the first population to be
vetted for self-reactivity. Immature B cells that express
autoreactive BCRs are functionally silenced or deleted; a
subset of these cells that exhibit autoreactivity of low
affinity are driven by self-antigen to enter the B1
compartment. Emigration of immature B cells to the
periphery and their acquisition of membrane-bound (m)IgD
antigen receptors indicates entry into the transitional B
cell compartment. Fully mature B cells subsequently move
to the follicle and can be delineated from other peripheral
B cell populations by a variety of cell surface markers,
including reduced expression of mIgM.
Many groups have documented age-associated changes
in B lymphopoiesis in variety of mouse strains [9–16]. A
common finding of those studies is the decline in absolute
numbers of pre-B cells, as measured by flow cytometry.
The reported severity of this decline varied from study to
study and from animal to animal, ranging from moderate
(but statistically significant) to extreme, depending on the
strain, sex and age of the mice studied, and on the
particular methods used to generate and analyze the data.
Some studies further correlated reduced pre-B cell
numbers with reduced numbers of immature and/or
transitional B cells [11,16,17]. Several mechanisms,
including failure to progress in development, and
increased apoptosis of both pro-B and pre-B cells, have
been purported to limit the pre-B cell pool in aged mice. It
has been shown in these animals that a proportion of pro-
B cells fail to progress in development to the pre-B cell
stage. This has been attributed to impaired expression of
pre-BCR components, including rearranged IgH and
λ5/VpreB surrogate light chains [16,18]. Age-related
reductions in pre-BCR components at the level of surface
expression are highly correlated with reduced
transcription of the molecules; reduced expression and
activity of E2A transcription factors have been specifically
implicated in the case of λ5/VpreB [19]. Notably, levels
of expression of recombinase activating gene (RAG)
proteins in individual pro-B and pre-B cells are similar
between aged and young mice, but total BM RAG
expression is reduced in aged animals because of
reduced numbers of pre-B cells [18].
Nevertheless, the relative importance of these impairments
is called into question by experimental evidence from our
laboratory, which demonstrates that aged immunoglobulin
transgenic mice also fail to generate new B cells efficiently
[12]. These immunoglobulin transgenic mice express a
mature, fully rearranged BCR very early in development,
thus obviating the need for endogenous IgH,  λ5, and
VpreB. These data indicate minimally that factors in
addition to expression of pre-BCR must limit B cell
production in older animals. If IgH, λ5, or VpreB was solely
limiting, then production should have been rescued by the
immunoglobulin transgenes. These data do not exclude
the possibility that signal transduction downstream from
the pre-BCR or transgenic BCR is impaired. Additionally,
both mRNA and protein levels of the survival molecule Bcl-
xL are reduced in pro-B and pre-B cells harvested from
aged as compared with young mice, and this may result in
the increased apoptosis observed in these cell
populations [15,20].
The possibility also exists that pre-B cells may be fewer in
number in aged mice because the numbers and/or activity
of their progenitors are limited. This explanation has not
been rigorously examined, but at least one group has
claimed that absolute numbers of pro-B cells remain
constant with aging [10]. Nonetheless, recent advance-
ments in cell sorting technologies have allowed more
detailed discrimination of rare BM subpopulations, and it
is now clear that absolute numbers of early B cell
progenitors also decline with age, including pro-B cells
and early B cell precursors/common lymphoid precursors.
Furthermore, diminished IL-7 responsiveness is correlated
with these reductions in cell numbers [21]. In vitro studies
also show that cultured pro-B/pre-B cells from aged mice
proliferate poorly in response to exogenous IL-7, but
surface expression of IL-7 receptor remains unchanged
[21–23]. Taken together, these findings suggest that
signal transduction via the IL-7 receptor may be impaired,
or that the crosstalk that occurs between the IL-7 receptor
and other receptors (e.g. pre-BCR), and is necessary for
development, is impaired.133
Interestingly, Morrison and coworkers [24] have shown
that multipotent hematopoietic stem cells (HSCs) increase
in numbers by as much as fivefold with age. Importantly,
however, in that study HSCs sorted from aged animals
and transferred to young irradiated recipients were
defective in their ability to reconstitute the B cell compart-
ment, but they retained their ability to reconstitute both the
T cell and myeloid compartments effectively. From these
data, the authors concluded that B lineage progenitor
activity declines with age, ultimately resulting in decreased
generation of mature B cells. Two other groups
investigating HSCs recently corroborated those findings
[25,26]. Further studies conducted both in our laboratory
[12] and in that of Weksler [27], in which the rate of new
B cell production was determined in aged as compared
with young mice following lymphopenia induced by γ-
irradiation or cyclophosphamide, demonstrated that the
absolute numbers of B cells generated per unit time in
both the BM and spleen are markedly reduced.
In addition to the reports outlined above, B lymphopoiesis
in aged animals has been studied as a function of
production rate to determine whether the described defect
in generative (or regenerative) capacity is confounded by
cells that progress through development more slowly.
Determination of production rate is most frequently
measured as rate of incorporation of bromodeoxyuridine
(BrdU) into dividing cells. Using this method, Kline and
coworkers [11] demonstrated that both pre-B and
immature B cell subsets incorporate BrdU more slowly in
aged than in young animals, concluding that B cell
maturation is retarded in aged mice. Recently, however,
investigators from the laboratory of Witte [17] contested
this notion, concluding that despite reduced numbers of
pre-B cells the rate of BrdU incorporation, and hence the
rate of new B cell production, does not change with age.
Furthermore, the authors of that report contend that total
numbers of immature and transitional B cells do not
decline with age, maintaining that ‘the major defect in B
cell development of old mice is the inability of newly made
cells to join the peripheral B cell compartment.’ They
hypothesize that new B cells may be unable to home to
the spleen efficiently. However, experimental evidence
from Albright and coworkers [28] demonstrates that
mature, splenic B cells transferred from aged or young
mice to young recipients localize in the spleen with
comparable efficiency. The discrepancies between the
findings of Johnson, Owen and Witte [17] and those of
other groups quite possibly reflect differences in
experimental protocol and/or mouse colonies.
Finally, one must also consider the influence of the aged
BM microenvironment on B lymphopoiesis as it occurs in
aged animals. Normal B cell development is critically
dependent on the BM microenvironment, with stromal
cells providing specialized niches that nurture
lymphopoiesis through coordinated expression of various
chemokines (e.g. SDF-1/CXCL12) and cytokines (e.g.
IL-7). Very few studies have explored molecular changes
in the BM microenvironment as a function of age. Stephan
and coworkers [22] reported that stroma derived from
aged animals is defective in its ability to release IL-7 and
support B lymphopoiesis in culture. Furthermore, Li and
colleagues [27] showed that when BM cells derived from
young mice are transferred to lethally irradiated recipients,
absolute numbers of splenic B cells (measured at 3 weeks
after transfer) are reduced in aged as compared with
young recipients. Therefore, these data suggest that both
B lineage intrinsic and extrinsic factors may limit
B lymphopoiesis in aged animals.
Most investigators agree that in humans, like mice, some
B lymphopoiesis continues for the lifetime of the organism.
It is also generally agreed that pathways of B cell
development change and progenitor activity declines as
humans mature from fetus to adult. In contrast, it is still a
matter of debate whether adult humans undergo the further
reductions in B cell output described in aged mice. As
one can easily imagine, experiments using human BM are
exceptionally challenging for a variety of reasons. Adult
marrow specimens are often of limited availability and
rarely come from normal donors. In addition, the precise
surface characteristics of BM B cell developmental inter-
mediaries are not fully defined in humans, but they clearly
differ from those defined in mice. Ultimately, variations in
human genotype and environmental experience, which are
not found in inbred mouse strains housed under controlled
conditions, confound results and potentially mask
differences in B lymphopoiesis due to aging.
However, McKenna and colleagues [29] conducted an
elegant and very thorough study of the aging human B cell
compartment in 2001, examining a total of 662 BM
specimens derived from 598 patients ranging in age from
2 months to 92 years. In that report the percentage of
B lymphocyte precursors was determined as a function of
age, and data from each patient were depicted as an
individual dot on a composite scatter plot. Although a
broad range was found at all ages, linear regression
analysis showed a statistically significant decline in
B lymphocyte precursors with increasing age. In contrast,
two other studies [30,31] concluded that production of
B cells in humans remains relatively constant throughout
adult life. Interestingly, both studies presented some data
that indicate that B lymphopoiesis declines with age but
these trends were not statistically significant. It should be
noted, however, that this lack of statistical significance is
probably due to the low numbers of patients examined
and/or the use of data presentation in which means were
calculated for groups containing individuals that differed in
age by as much as 26 years. Because aging is a gradual
process that is asynchronous within the population, a
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group design is inappropriate for full evaluation of changes
that occur over time. Further investigation, in which large
numbers of individuals are analyzed separately, preferably
in terms of absolute numbers of B cell precursors, is
needed to resolve these discrepancies.
As discussed above, many factors may contribute to
reduced B cell production in aged mice, including
possible defects in levels/function of both IL-7 and its
receptor. Rossi and coworkers [30] state that IL-7 is
unnecessary for B cell development in humans, and
suggest that this may account for the species related
differences reported by some investigators. Indeed, two
studies [32,33] concluded that human B cell development
is IL-7 independent, whereas two others demonstrate that
IL-7 is required [34,35]; the former utilized fetal derived
tissue and the latter used adult BM. It is well documented
that human B cell development differs significantly
between fetus and adult. Moreover, researchers in the
laboratory of Vieira [36] recently demonstrated that deletions
of IL-7 or IL-7 receptor permit B cell development in fetal
but not adult mice. Taken together, these studies indicate
that IL-7/IL-7 receptor may in fact be essential for
B lymphopoiesis in adult humans and, importantly, may
play a role in aging.
The aged peripheral B cell repertoire: what
does it look like and how did it get there?
Because the number of functional B cell progenitors
decreases with age, it is logical to expect that the
numbers of mature B cells in the periphery would also
decrease. Experimental evidence from several groups,
however, demonstrates that mature B cell numbers are
roughly equivalent in aged and young mice [12,17]. This
apparent paradox can be explained in part by the increase
in lifespan (measured using BrdU incorporation) of mature
B cells in the periphery of aged mice [11]. Careful
dissection of splenic B cell subsets by our laboratory and
others also revealed significant alterations in sub-
population distribution as mice age [12,37]. Specifically,
the percentage of naïve follicular B cells declines
dramatically, whereas subsets of antigen-experienced
cells increase. Importantly, the type of antigen-
experienced cells that accumulate varies from aged
mouse to aged mouse (even among cohabiting animals),
and can include increased numbers of one or more of the
following B cell subsets [12]: MZ, CD5+ B1-like, and
memory. Experiments conducted in our laboratory show
that within the spleens of aged mice it is only these
antigen-experienced subpopulations that incorporate
BrdU very slowly, and hence have an extended lifespan
(Johnson SA, Cambier JC, unpublished observation).
These data are consistent with a previous report that
activated B cells and their clonal descendants have a
longer lifespan than do resting B cells [38]. Importantly,
elevated total serum immunoglobulin concentrations,
including elevation in autoantibodies, distinguish mouse
strains with increased numbers of MZ, B1, and memory
B cell subsets, and not surprisingly aged mice [12,39–41].
Finally, stable B cell expansions with clonal IgH have been
detected in aged, unimmunized mice [37,42]. These
clonal B cell populations tend to be CD5+, and in some
instances they are thought to be precursors of two B cell
derived cancers, namely chronic lymphocytic leukemia and
multiple myeloma [37]. The origin of CD5+ B1 cells in
young, adult mice is a controversial matter. Some
investigators maintain that B1 and B2 cells derive from
distinct progenitors (for review see [43]), whereas others
believe that they derive from a common progenitor or ‘B-0’
cell (for review see [44]). In the latter case, surface
expression of CD5 and commitment to the B1 pathway
requires antigen receptor engagement under specific
conditions (e.g. the absence of T cell help) [45]. This
requirement for entry into the B1 pathway selects for cells
that bear receptors that have low affinity for
environmental/self antigens. Importantly, the CD5+ B cell
expansions found in the periphery of aged animals are not
found among B cell precursors in the BM [37]. Thus, it
has been hypothesized that these cells develop in the
periphery, probably as a result of encounters with
environmental antigens.
The studies presented above demonstrate that the
peripheral B cell compartment in aged mice is ‘skewed’ in
favor of long-lived, antigen-experienced cells, but they do
not address the root cause of this shift. Potential causal
explanations include the following: BM B cell production is
depressed because peripheral B cells live longer;
alternatively, peripheral B cells live longer because BM B
cell production is depressed. If the former were true then
one might predict that ablation of long-lived peripheral B
cells in aged animals would restore ‘young-like’ B
lymphopoiesis, and ultimately a young-like peripheral
repertoire. To address this hypothesis, Li and coworkers
[27] ablated the B cell compartment with cyclophospha-
mide and found that the subsequently regenerated
repertoire was ‘old-like’, disproving this notion.
In contrast, several lines of evidence support the second
alternative described above – that reduced BM B lympho-
poiesis may drive the selective increase in antigen-
experienced B cell numbers in the periphery. In young
adult mice, only a fraction (10%) of newly produced
B cells enter the mature B cell compartment and are main-
tained as part of the naïve preimmune repertoire [46,47]. It
has recently become clear that a large proportion of newly
produced B cells bear surface immunoglobulin that have
some degree of self-reactivity (including environmental
and autoantigens), and that these cells are normally
eliminated at one of two distinct developmental check-
points [48]. Whether these cells survive or are eliminated
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depends in part on self-antigen induced BCR signal
strength and on the presence or absence of non-self-
reactive B cells that compete for space (for detailed
review, see [49]). Interestingly, in contrived circumstances
in which naïve B cells are present, autoreactive B cells
from young HEL (Hen Egg Lysozyme)/anti-HEL double
transgenic animals are excluded from the follicular niches
and die rapidly [50]. In the absence of naïve competitors,
however, these same cells enter the follicle and survive.
Thus, in normal, young adult animals, competition for
limited follicular niches excludes the majority of self-
reactive B cells from the peripheral repertoire. Conversely,
it has been shown that in aged animals self-reactive B
cells gain entry to follicular niches and survive [51]. We
postulate that this observed difference (between young
and aged animals) reflects the reduction in naïve
competitor B cells in the aged environment as a result of
reduced B lymphopoiesis. These results resonate with
those derived from analysis of the behavior of antigen-
experienced B cells in young mice.
Analyses of knockout mice, including those for IL-7, IL-7
receptor, λ5, and the motheaten viable mouse (a naturally
occurring hypomorph of SHP-1) in which B lymphopoiesis
is impaired and competition is reduced, reveal a skewed
peripheral B cell compartment dominated by antigen-
experienced cells [39,41,52]. Furthermore, Hao and
Rajewsky [53] demonstrate that inducible deletion of
RAG-2 in young adult mice results in the gradual loss of
naïve follicular B cells, but not of MZ or B1 B cells. Recent
studies conducted in our laboratory also suggest that
reduced influx of B cells from the BM drives the selection
of antigen-experienced cells into the peripheral compart-
ment. Using two different experimental approaches, we
found that when B lymphopoiesis is artificially depressed
in young animals, either by repeated injection of anti-IL-7
antibodies or by reconstitution of young lethally irradiated
recipients with limiting numbers of HSCs from young
animals, a skewing of the peripheral compartment results
(Johnson SA, Cambier JC, unpublished observations). It is
important to note a caveat in the ‘limited B lymphopoiesis’
model systems described above; unlike in aged mice, total
numbers of splenic B cells are reduced in these mice, as
compared with controls. This difference in observed cell
number may simply reflect a difference in the time (weeks/
months versus years) over which cells are allowed to
accumulate. However, it may also reflect differences in the
splenic microenvironment between young and aged
animals. That is, the microenvironment of the old animal
may further extend the lifespan of antigen-experienced
cells or promote the survival and/or proliferation of
antigen-experienced B cells.
Cytokine networks and aging
The peripheral T cell compartment of aged mice is also
skewed toward antigen-experienced cells, including CD4+
memory, CD8+ memory, and NK1.1+ cells (for review see
[54]). In addition, multiple groups have reported changes
in cytokine profiles with aging, and it is now clear that age-
associated shifts in T cell subset composition are
correlated with the progressive decreases in IL-2, and
increases in IL-4, IL-5, and IFN-γ [55–59]. Importantly, the
depressed level of IL-2 found in aged mice may help to
sustain the large pool of memory T cells and their cytokine
products. In young adult mice a balance between IL-15
and IL-2 provides homeostatic control of CD8+ memory T
cell numbers; IL-15 induces proliferation, and IL-2 induces
death [60]. Data from IL-2 or IL-2 receptor knockout
mouse models suggest that IL-2 deficiency allows
unchecked survival of memory T cells. Perhaps a similar
mechanism is at work in the aged spleen.
Aging dependent changes in cytokine networks may also
modify the B cell compartment. Spencer and Daynes [61]
demonstrated that dysregulated macrophages in the aged
spleen are responsible for the overproduction of IL-6,
tumor necrosis factor (TNF)-α, and IL-12. In vitro data
from that group further show that IL-12 stimulates IL-10
production by CD5+ B cells and IFN-γ by NK cells. As
noted above, numbers of CD5+ B cells are increased in
the spleens of many aged animals. This overproduction of
IL-10, and particularly IFN-γ, may strongly influence the
ratio of naïve follicular to antigen-experienced B cells in
the aged spleen. Both cytokines are known to enhance
release of B cell activating factor (BAFF; also known as
BLyS, TALL-1, zTNF4, and THANK) by monocytes [62].
BAFF is a member of the TNF superfamily that specifically
regulates B cell proliferation and survival. Interestingly
from an aging standpoint, transgenic mice that
overexpress BAFF have increased numbers of MZ cells
and high levels of autoantibodies in their serum, prompting
Groom and coworkers [40] to hypothesize that excess
BAFF in these animals overrides a critical tolerance
checkpoint by providing a survival signal to self-reactive B
cells. It is currently unknown whether BAFF becomes
dysregulated as a function of aging, but it is an intriguing
possibility that warrants investigation.
The B cell contribution to poor humoral
immunity in the aged: defective B cells or
defective B cell populations?
As referenced in the Introduction section above, aging is
accompanied by a generalized dysregulation of many
immune cell types. The studies described above clearly
indicate that, in addition to well-documented senescence
in the T cell compartment (for review see [63]), senescence
in the B cell compartment probably also contributes to the
deterioration of humoral immunity that is evident in many
aged individuals. The following question then arises; does
the B cell contribution to poor humoral immunity in the
aged result from functional defects in individual B cells or
from shifts in the cellular constitution of peripheral
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lymphoid organs from naïve to antigen-experienced cells?
We favor the latter hypothesis. It is well documented in
both mice and humans that antibody responses in the
aged are lacking in quality rather than quantity, indicating
minimally that B cells from aged animals are fully
competent to produce antibody (for review see [64]). The
work of Dailey and coworkers [65] further supports the
contention that individual follicular B cells from aged mice
function normally. Experiments conducted by this group
showed that when equal numbers of follicular B cells were
transferred from either aged or young immunoglobulin
transgenic donors to young primed recipients, specific
thymus-dependent antibody responses generated upon
challenge were equivalent, regardless of donor age.
Likewise, experiments utilizing antigens that selectively
stimulate CD5+ B cells (e.g. trinitrophenyl–ficoll) or MZ
B cells (e.g. native dextran) also show that specific
antibody responses are equivalent in young and aged
mice, again indicating that the function of these cells is
normal [66,67].
So, how do shifts in the B cell constitution of peripheral
lymphoid organs from naïve to antigen-experienced translate
into the poor quality antibodies generated by aged
animals? We propose that because naïve follicular B cells
are in short supply, aged immunosenescent animals must
rely, in part, on antigen-experienced (MZ, CD5+ B1-like,
and memory) B cells to defend themselves against new
immunologic insults. If this is the case, then one would
predict that the antibody response of aged mice would
bear the hallmarks of antibodies produced by antigen-
experienced cells that were initially expanded and
selected by cross-reactive antigens or are B1 cells (i.e. it
should be of relatively low affinity and poly/self-reactive). A
variety of experimental evidence supports this hypothesis.
First, aging is associated with elevation in serum auto-
antibodies [12,68]. This elevation in autoantibodies has
been documented by multiple groups using a variety of
mouse strains, and includes antibodies reactive with
double-stranded DNA, single-stranded DNA, and histones.
In addition, autoantibodies against thymocytes and idio-
typic determinants of BCR are detectable. Interestingly,
the former have been implicated in impaired T cell poiesis
[69], and the latter in suppression of specific B cell
responses [70]. Importantly, autoantibodies in the sera of
aged animals are rarely accompanied by autoimmune
disease, probably because of their low affinity.
Furthermore, studies from the laboratory of Weksler [71]
demonstrated that aged mice immunized with a classical
thymus dependent antigen, namely sheep erythrocytes
(SRBC), produce fewer anti-sheep erythrocyte antibody
secreting cells than do their young counterparts (probably
from follicular B cells), but they produce significant levels
of antibody reactive with the classical autoantigen,
bromelain-treated mouse erythrocytes, which are not seen
in young mice. This suggests a shift in the cells
responding to the antigen from follicular B cells in young
mice to antigen-experienced cells in old mice.
Second, studies conducted in the early 1970s [72–74]
revealed that antibodies produced by aged as compared
with young mice in response to antigenic challenge were
of lower affinity and avidity. More recently, Cerny and
colleagues [75] have extended these observations by
demonstrating that antibodies produced by aged mice
immunized with phosphorylcholine immunogens are not
only of lower affinity and avidity but are also less protective
against infection than those produced by young mice.
Thus, the poor quality of the primary humoral response of
aged animals probably reflects the mixed response of
specific naïve B cells and polyreactive antigen-experi-
enced B cells, rather than some B cell functional defect.
Also contributing to the lower affinity of humoral
responses in aged animals may be the recently described
impairment of somatic hypermutation [76]. Because
germinal centers (GCs) are known to be the primary site
of immunoglobulin somatic mutation and affinity
maturation, these data point to a defect in GC formation
and/or function. Not surprisingly, immunohistologic and
flow cytometric analyses show that both the number and
volume of GCs decline gradually as a function of age (for
review see [77]). Because GCs arise primarily from
antigen stimulated follicular B cells, this may simply reflect
the reduced number of follicular cells in aged animals.
However, precise dissection of the GC reaction shows
that in aged mice senescence in both the B cell and T cell
compartments contributes to the changes in GC output.
Specifically, experiments in which severe combined
immunodeficient (scid) mice were reconstituted with
CD4+ T cells and unfractionated B cells, from un-
immunized young or aged donors in reciprocal combina-
tions, demonstrated that the somatic hypermutation
process was severely limited when either B or T cells
came from aged donors, and was comparable to that in
intact young adult animals only when both cell types were
derived from young donors [78]. Importantly, these
experiments did not address the role of the aged splenic
microenvironment, and it is quite possible that defects in
FDC function also contribute to the age-related
impairment in the GC reaction [79]. Nonetheless, they
indicate that, in addition to the impact of B cell
compartment (e.g. follicular to MZ/B1 skewing), ‘defective’
T cell help may contribute to the poor quality of the
humoral response of aged individuals.
Study of the GC reaction in healthy aged humans is
impractical for obvious reasons. Nonetheless, the products
of the GC reaction, namely antibodies, have been studied.
In aged humans, as in mice, antibody affinity is reduced and
total levels of serum autoantibodies are increased [80,81].
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Again, as in mice, these autoantibodies lack specificity for
organs and rarely contribute to autoimmune disease [2].
The demonstration of increased autoantibodies in the serum
of elderly humans is of importance, however, because it
indicates that a similar state of immune dysregulation exists
in aged humans and mice.
Current literature contains many reports describing a shift
in T cell subsets from naïve to memory in aged humans (for
review see [3]). Unfortunately, a paucity of information
exists regarding the nature of the B cell compartment in
these same individuals. Available evidence suggests that
the total number of B cells declines as human beings age
[82]. Although on the surface this seems counter to the
situation in mice, one must remember that studies of aged
humans are confined to examination of peripheral blood
B cells. Certain B cell subsets, including MZ B cells, do not
recirculate, and thus would not be accounted for in studies
of peripheral blood [52]. As noted previously, total
numbers of MZ B cells increase in many aged mice.
Moreover, data reported as percentages, rather than as
total numbers, indicate that CD27+ memory B cells
increase in the blood of elderly humans [82]. Aged humans
further parallel aged mice in dysregulation of measurable
cytokines. Several groups reported that aged, as compared
with adult, humans have increased levels of IL-4, IFN-γ, and
IL-12 [83,84]. These cytokines all have strong potential to
sustain long-lived antigen-experienced B cells.
Conclusion
As illustrated in Fig. 1, we believe that aging is associated
with decreased B lymphopoiesis in the BM, which
ultimately limits the output of new B cells to the periphery.
Under these conditions, lack of competition for space in
peripheral niches allows environmental/self-reactive B cells,
which would normally be silenced, to enter and survive.
Over time, these self-reactive B cells, as well as antigen-
experienced B cells (CD5+ B1-like, MZ, and memory),
accumulate and eventually dominate the peripheral B cell
compartment. It is likely that cytokine dysregulation helps
to maintain this skewing of B cell populations. Further-
more, available data indicate that individual B cells of all
subtypes function normally, but that humoral immunity is
greatly diminished in many aged animals. We maintain that
this decline in humoral immunity reflects the forced
reliance on antigen-experienced B cells, rather than on
naïve, follicular B cells, to respond to new immunologic
insults; lack of appropriate T cell help and ‘defective’ FDC
function probably also play a role.
If one believes, as we do, that a causal link exists between
decreased BM production of B cells and decreased
humoral immunity, then one might hypothesize that
increasing B cell output to ‘young-like’ levels would
improve humoral immunity. In fact, recent experiments
conducted in our laboratory demonstrate that
reconstitution of aged mice with HSCs from young mice
re-establishes a normal, young-like peripheral B cell
compartment, consisting primarily of naïve, follicular B
cells (SA Johnson and JC Cambier, unpublished
observation). We have not yet measured the impact of this
treatment on humoral immunity but we have high hopes.
We are also investigating other strategies for improving B
cell output from the BM of aged individuals. For example,
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Figure 1
The B cell compartment changes with age. BM, bone marrow; SPL, spleen.138
because decreased B cell production may result from
impaired signaling through IL-7 receptors, it might be
possible to bypass this defect using a gene therapy
approach. Such approaches, while not providing a ‘fountain
of youth’, may someday enhance the quality of life of the
aged by increasing their resistance to infectious agents.
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